Science & Research
SeaStar Medical Advances Organ-Saving Therapies for Critically Ill Patients
SeaStar Medical is developing innovative medical devices targeting acute kidney injury, leveraging FDA Breakthrough Device Status to potentially transform treatment for critically ill patients across multiple serious conditions.
Biotech Startup Lionheart Health Advances in $101M XPRIZE Healthspan Competition
Lionheart Health has been selected as one of 40 semi-finalists in a global competition aimed at developing treatments to dramatically extend healthy human aging. The company's innovative bioelectric signaling technology could potentially restore multiple age-related declines in just one year.
New Study Validates PREVENT Risk Calculator for Heart Attack Prediction
A study of nearly 7,000 adults demonstrates the accuracy of the American Heart Association's PREVENT risk calculator in identifying individuals with potential heart disease risk, using coronary calcium scores as a complementary screening tool.
Creative Biolabs Advances Lactobacillus Research with Comprehensive Probiotic Development Services
Creative Biolabs launches advanced Lactobacillus development solutions, offering comprehensive screening, validation, and engineering services for probiotic research. The company's multi-dimensional approach aims to enhance understanding of microbiome interactions and potential therapeutic applications.
New Research Illuminates Potential Link Between Epstein-Barr Virus and Multiple Sclerosis
Scientific research is uncovering a complex relationship between Epstein-Barr virus exposure and Multiple Sclerosis, highlighting the potential for deeper understanding of disease mechanisms and future treatment strategies.
Quantum BioPharma Advances Multiple Sclerosis Drug Toward Clinical Trials
Quantum BioPharma has signed an agreement with a contract research organization to prepare an Investigational New Drug application for Lucid-21-302, a potential breakthrough therapy for multiple sclerosis that could prevent neurological damage.
American Heart Association Awards $1.2 Million in Food as Medicine Research Grants
The American Heart Association has awarded $1.2 million in planning grants to 12 scientific researchers to develop clinical trial protocols exploring food intervention strategies for chronic disease management. These grants aim to test approaches that could transform healthcare delivery and potentially reduce diet-related medical costs.
GeoVax Develops Multi-Antigen COVID-19 Vaccine Targeting Immunocompromised Populations
GeoVax's innovative GEO-CM04S1 vaccine addresses critical gaps in COVID-19 immunization strategies by offering broad, durable protection for vulnerable populations as HHS shifts towards risk-based vaccine recommendations.
Creative Biolabs Unveils Advanced Bispecific Antibody Platform at Industry Conference
Creative Biolabs demonstrates cutting-edge bispecific antibody technology with potential to revolutionize cancer immunotherapy, showcasing customized development capabilities and innovative research approaches.
Creative Biolabs to Explore Neural Mechanisms of Survival Behaviors in Upcoming Webinar
A pioneering webinar hosted by Creative Biolabs will delve into the complex neural circuits that govern fundamental survival behaviors, offering researchers insights into how organisms perceive danger and make critical decisions.
Sedentary Behavior Linked to Higher Cardiac Event Risk After Hospitalization
A new study reveals that prolonged sedentary time increases the risk of subsequent cardiac events within a year after hospitalization. Replacing sitting time with light physical activity or sleep can significantly reduce cardiovascular risks.
CNS Pharmaceuticals Advances Brain Cancer Treatment, Reports Q1 Financial Results
CNS Pharmaceuticals is progressing its brain cancer treatment TPI 287, with increased R&D spending and plans for a Phase 2 study in recurrent glioblastoma multiforme, while maintaining financial runway into 2026.
NanoViricides Advances Broad-Spectrum Antiviral Drug, Eyes Multiple Phase II Trials
NanoViricides is progressing its NV-387 drug candidate across multiple viral infections, with pending Phase II trials for MPox and emerging programs for measles and avian flu, highlighting significant potential in antiviral treatment development.
Soligenix Advances Phase 3 Trial for Cutaneous T-Cell Lymphoma Treatment, Zacks Report Shows Promise
Soligenix continues enrollment in its Phase 3 HyBryte trial for cutaneous T-cell lymphoma, with Zacks Research highlighting the trial's high potential for success and anticipated topline results in 2026.
Telomir Pharmaceuticals Reveals Innovative Silver(II) Antimicrobial Drug Candidate
Telomir Pharmaceuticals has developed Telomir-Ag2, a novel Silver(II) complex with broad-spectrum antimicrobial properties targeting significant medical markets including wound care and infection treatment.
Calidi Biotherapeutics Advances Cancer Immunotherapy Platform, Reduces Quarterly Losses
Calidi Biotherapeutics has made significant progress in its oncology research, receiving FDA clearance for a stem cell-based immunotherapy and presenting promising data on its Redtail virotherapy platform while simultaneously reducing operational expenses.
New Study Suggests Combining Fluoride and Iodine Could Enhance Cavity Prevention
A recent study reveals that using fluoride and iodine together may significantly reduce tooth decay in children, potentially offering a more effective approach to dental care than fluoride treatment alone.
Creative Biolabs Advances Antibody Engineering with Innovative Glycosylation Technology
Creative Biolabs has developed a sophisticated analytical platform for monoclonal antibody glycan profiling, enhancing therapeutic antibody effectiveness through precise Fc region modifications. These technological improvements could significantly impact biopharmaceutical drug development.
Tevard's tRNA Therapy Offers Promising Approach to Duchenne Muscular Dystrophy Treatment
Tevard Biosciences demonstrated a breakthrough in treating Duchenne Muscular Dystrophy by restoring full-length dystrophin protein using suppressor tRNA therapy, potentially offering hope for patients with nonsense mutations.
NanoViricides Advances Promising Antiviral Drug Against Measles and MPox
NanoViricides is developing NV-387, a potential breakthrough treatment for Measles and MPox amid rising global case counts and limited medical interventions. The drug represents a critical advancement in addressing urgent infectious disease challenges.
Silo Pharma Advances PTSD Treatment with FDA-Requested Safety Study
Silo Pharma is conducting a critical safety study on its intranasal PTSD treatment SPC-15, which could potentially provide a new therapeutic option for patients struggling with stress-related disorders by meeting FDA requirements for clinical advancement.
CNS Pharmaceuticals Raises $5 Million in Public Offering to Advance Brain Cancer Research
CNS Pharmaceuticals secures $5 million in funding through a public offering, aimed at supporting the development of innovative brain cancer treatments, with a focus on its lead drug candidate Berubicin.
Annovis Bio Advances Alzheimer's Treatment with Phase 3 Clinical Trial
Annovis Bio has initiated a pivotal Phase 3 clinical trial for buntanetap, a potential treatment for early Alzheimer's disease, with the potential to address symptomatic and disease-modifying aspects of the condition.
New Study Reveals High Mortality Rates in Broken Heart Syndrome
A comprehensive national study tracked Takotsubo cardiomyopathy rates from 2016 to 2020, revealing persistently high death and complication rates across different demographic groups. The research highlights significant gender and age-related variations in this stress-induced heart condition.
Researchers Highlight Promising Anticancer Natural Product Synthesis Challenges
A systematic review of heterocyclic natural products reveals significant potential for anticancer drug development while identifying key challenges in synthesizing these compounds efficiently and sustainably.
Giant Sequoia Lands Coalition Marks Significant Progress in Forest Restoration and Wildfire Resilience
The Giant Sequoia Lands Coalition has made substantial strides in protecting giant sequoia ecosystems from extreme wildfires, completing restoration treatments in over half of the world's sequoia groves and addressing critical threats to these irreplaceable forests.
Medical Alliance Launches Campaign Challenging COVID-19 mRNA Vaccine Use in Children and Pregnant Women
The Independent Medical Alliance's 'Smart Moms Ask' campaign aims to halt mRNA COVID-19 vaccinations for children and pregnant women, citing potential health risks based on recent studies and data.
InVitro International Reports Growth in Non-Animal Testing Technologies Amid Regulatory Shifts
InVitro International reports modest sales growth and highlights increasing global momentum toward non-animal testing methods in cosmetics and personal care industries, signaling potential regulatory changes.
SeaStar Medical Achieves Six FDA Breakthrough Device Designations, Promising New Hope for Critical Care Patients
SeaStar Medical has secured six FDA Breakthrough Device Designations for its Selective Cytopheretic Device (SCD) therapy, targeting life-threatening conditions with limited treatment options. These designations highlight the potential to transform care for patients with acute kidney injury, inflammatory responses, and other critical health challenges.
Study Reveals Link Between Ultra-Processed Foods and Psoriasis Risk
New research published in Nutrients journal suggests a significant correlation between ultra-processed food consumption and increased psoriasis risk, highlighting potential dietary implications for patient health.